{"id":7567,"date":"2026-05-11T10:30:56","date_gmt":"2026-05-11T02:30:56","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-05-11\/"},"modified":"2026-05-11T10:30:56","modified_gmt":"2026-05-11T02:30:56","slug":"9-54","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-54\/","title":{"rendered":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-05-11\uff5c\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-05-11\">2026 \u5e74 05 \u6708 11 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 13 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 3 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#5B9BD5\">\u6578\u4f4d\u5065\u5eb7\u91ab\u7642\u79d1\u6280<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/drug-development-ma-big-pharmas-showcase-measurable-impact-ai\" rel=\"noopener nofollow\" target=\"_blank\">\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-05-11\" itemprop=\"datePublished\">2026-05-11<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cf\u25cb<\/span><span class=\"c-hype-tx\">4\/5 \u00b7 \u91cd\u5927\u8a0a\u865f<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>PFE<\/b> Pfizer <span class=\"chg chg-down\">\u25bc3.02% $25.68<\/span><\/span><span class=\"stk stk-us\"><b>NVS<\/b> Novartis <span class=\"chg chg-up\">\u25b20.44% $146.03<\/span><\/span><span class=\"stk stk-other\"><b>ROG<\/b> Roche <span class=\"chg chg-up\">\u25b22.48% $140.66<\/span><\/span><span class=\"stk stk-us\"><b>JNJ<\/b> Johnson &amp; Johnson <span class=\"chg chg-down\">\u25bc0.53% $221.32<\/span><\/span><span class=\"stk stk-us\"><b>AZN<\/b> AstraZeneca <span class=\"chg chg-up\">\u25b20.18% $182.85<\/span><\/span><span class=\"stk stk-tw\"><b>4133<\/b> \u4e9e\u8afe\u6cd5 <span class=\"chg chg-down\">\u25bc0.23% $21.9<\/span><\/span><span class=\"stk stk-other\"><b>3176<\/b> \u57fa\u4e9e <span class=\"chg chg-down\">\u25bc0.91% $32.75<\/span><\/span><\/div>\n<img decoding=\"async\" alt=\"\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d\" class=\"lazyload c-img\" height=\"540\" loading=\"lazy\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271170%27%20height%3D%27540%27%20viewBox%3D%270%200%201170%20540%27%3E%3Crect%20width%3D%271170%27%20height%3D%27540%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/witology.com.tw\/wp-content\/uploads\/2026\/05\/featured_1-11.png\" width=\"1170\"\/>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u5168\u7403\u4e3b\u8981\u88fd\u85e5\u5ee0\u5546\u958b\u59cb\u516c\u958b\u5c55\u793a\u4eba\u5de5\u667a\u6167\u5728\u85e5\u7269\u7814\u767c\u5404\u968e\u6bb5\u7684\u5be6\u969b\u61c9\u7528\u6210\u6548\uff0c\u5f9e\u65e9\u671f\u5316\u5408\u7269\u7be9\u9078\u5230\u4f75\u8cfc\u6a19\u7684\u8a55\u4f30\u90fd\u6709\u91cf\u5316\u6578\u64da\u652f\u6490\u3002\u9019\u6a19\u8a8c\u8457\u88fd\u85e5\u7522\u696dAI\u61c9\u7528\u5f9e\u6982\u5ff5\u9a57\u8b49\u968e\u6bb5\u9032\u5165\u898f\u6a21\u5316\u5546\u696d\u90e8\u7f72\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403AI\u85e5\u7269\u767c\u73fe\u5e02\u5834\u898f\u6a21\u9810\u8a08\u5f9e2023\u5e74\u768414\u5104\u7f8e\u5143\u6210\u9577\u81f32030\u5e74\u7684147\u5104\u7f8e\u5143\uff0c\u5e74\u8907\u5408\u6210\u9577\u7387\u905445%\u3002\u76ee\u524d\u6709\u8d85\u904e150\u500bAI\u8f14\u52a9\u958b\u767c\u7684\u85e5\u7269\u9032\u5165\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\uff0c\u8f032020\u5e74\u589e\u9577300%\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>AI\u5728\u88fd\u85e5\u7522\u696d\u7684\u61c9\u7528\u6b63\u5f9e\u5be6\u9a57\u6027\u8cea\u8f49\u5411\u6838\u5fc3\u6230\u7565\u5de5\u5177\uff0c\u5c07\u91cd\u65b0\u5b9a\u7fa9\u85e5\u7269\u958b\u767c\u7684\u6210\u672c\u7d50\u69cb\u8207\u6642\u7a0b\u3002\u50b3\u7d71\u65b0\u85e5\u958b\u767c\u5e73\u5747\u8017\u664212-15\u5e74\u3001\u6210\u672c26\u5104\u7f8e\u5143\uff0cAI\u6280\u8853\u6709\u671b\u5c07\u6642\u7a0b\u7e2e\u77ed30-50%\uff0c\u5927\u5e45\u964d\u4f4e\u5931\u6557\u7387\u3002\u9019\u5c07\u4fc3\u4f7f\u88fd\u85e5\u5ee0\u52a0\u901f\u6295\u8cc7AI\u5e73\u53f0\uff0c\u4e26\u900f\u904e\u4f75\u8cfc\u65b9\u5f0f\u5feb\u901f\u53d6\u5f97\u76f8\u95dc\u6280\u8853\u80fd\u529b\uff0c\u91cd\u5851\u6574\u500b\u751f\u91ab\u7522\u696d\u7684\u7af6\u722d\u683c\u5c40\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>AI\u8f14\u52a9\u85e5\u7269\u958b\u767c\u7684\u5be6\u969b\u6548\u76ca\u4ecd\u9700\u9577\u671f\u9a57\u8b49\uff0c\u76ee\u524d\u591a\u6578\u6210\u529f\u6848\u4f8b\u96c6\u4e2d\u5728\u65e9\u671f\u7814\u767c\u968e\u6bb5\uff0c\u80fd\u5426\u5728\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u7dad\u6301\u512a\u52e2\u5c1a\u5f85\u89c0\u5bdf\uff0c\u4e14\u76e3\u7ba1\u6a5f\u69cb\u5c0dAI\u6f14\u7b97\u6cd5\u7684\u5be9\u6838\u6a19\u6e96\u4ecd\u5728\u5efa\u7acb\u4e2d\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>\u4e3b\u8981\u88fd\u85e5\u5ee0Q4\u8ca1\u5831\u4e2dAI\u6295\u8cc7\u9810\u7b97\u914d\u7f6e<\/li><li>FDA\u767c\u5e03AI\u8f14\u52a9\u85e5\u7269\u958b\u767c\u6307\u5c0e\u539f\u5247<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>AI\u958b\u767c\u85e5\u7269\u7684Phase II\/III\u8a66\u9a57\u6210\u529f\u7387\u7d71\u8a08<\/li><li>\u88fd\u85e5\u5ee0AI\u5e73\u53f0\u4f75\u8cfc\u6848\u4f8b\u589e\u52a0<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>AI\u539f\u751f\u85e5\u7269\u7684\u4e0a\u5e02\u6642\u7a0b\u8207\u50b3\u7d71\u85e5\u7269\u6bd4\u8f03<\/li><li>\u76e3\u7ba1\u6a5f\u69cb\u5efa\u7acbAI\u85e5\u7269\u5be9\u6838\u6a19\u6e96\u6846\u67b6<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>AI\u771f\u7684\u80fd\u8b93\u65b0\u85e5\u958b\u767c\u8b8a\u5feb\u8b8a\u4fbf\u5b9c\u55ce\uff1f<\/summary><p>\u76ee\u524dAI\u4e3b\u8981\u5728\u65e9\u671f\u85e5\u7269\u8a2d\u8a08\u968e\u6bb5\u5c55\u73fe\u512a\u52e2\uff0c\u80fd\u5c07\u5316\u5408\u7269\u7be9\u9078\u6642\u9593\u5f9e\u6578\u6708\u7e2e\u77ed\u81f3\u6578\u9031\uff0c\u4f46\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u7684\u52a0\u901f\u6548\u679c\u4ecd\u9700\u66f4\u591a\u5be6\u8b49\u6578\u64da\u652f\u6490\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u54ea\u4e9b\u88fd\u85e5\u516c\u53f8\u5728AI\u61c9\u7528\u4e0a\u8d70\u5f97\u6700\u524d\u9762\uff1f<\/summary><p>Roche\u3001Novartis\u3001Pfizer\u7b49\u5927\u5ee0\u900f\u904e\u5167\u90e8\u7814\u767c\u8207\u5916\u90e8\u4f75\u8cfc\u96d9\u8ecc\u4e26\u9032\uff0c\u800c\u65b0\u5275\u5982Recursion\u3001Exscientia\u7b49AI\u539f\u751f\u516c\u53f8\u5247\u5c08\u6ce8\u65bc\u5e73\u53f0\u6280\u8853\u958b\u767c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u53f0\u7063\u751f\u91ab\u516c\u53f8\u6709\u6a5f\u6703\u5728AI\u85e5\u7269\u958b\u767c\u6f6e\u6d41\u4e2d\u53d7\u76ca\u55ce\uff1f<\/summary><p>\u53f0\u7063\u7684CDMO\u696d\u8005\u5982\u4fdd\u745e\u3001\u53f0\u5eb7\u53ef\u627f\u63a5AI\u8a2d\u8a08\u85e5\u7269\u7684\u4ee3\u5de5\u9700\u6c42\uff0c\u800c\u4e9e\u8afe\u6cd5\u7b49\u9ad4\u5916\u8a3a\u65b7\u516c\u53f8\u5247\u53ef\u7d50\u5408AI\u6280\u8853\u63d0\u5347\u7cbe\u6e96\u91ab\u7642\u80fd\u529b\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/drug-development-ma-big-pharmas-showcase-measurable-impact-ai\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#ED7D31\">\u91ab\u7642\u5668\u6750<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/medtech\/roche-shell-out-1b-acquire-pathai-move-boost-ai-based-dx-algorithms\" rel=\"noopener nofollow\" target=\"_blank\">Roche\u65a5\u8cc7\u6700\u9ad810\u5104\u7f8e\u5143\u6536\u8cfcPathAI\uff0c\u5f37\u5316\u4eba\u5de5\u667a\u6167\u8a3a\u65b7\u80fd\u529b<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-05-11\" itemprop=\"datePublished\">2026-05-11<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-other\"><b>ROG<\/b> Roche <span class=\"chg chg-up\">\u25b22.48% $140.66<\/span><\/span><span class=\"stk stk-other\">PathAI <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><span class=\"stk stk-tw\"><b>4133<\/b> \u4e9e\u8afe\u6cd5 <span class=\"chg chg-down\">\u25bc0.23% $21.9<\/span><\/span><span class=\"stk stk-other\"><b>4117<\/b> \u666e\u751f <span class=\"chg chg-flat\">\u25000.00% $4.3<\/span><\/span><span class=\"stk stk-us\"><b>ILMN<\/b> Illumina <span class=\"chg chg-up\">\u25b22.29% $141.88<\/span><\/span><span class=\"stk stk-us\"><b>TMO<\/b> Thermo Fisher <span class=\"chg chg-down\">\u25bc1.99% $465.0<\/span><\/span><span class=\"stk stk-us\"><b>ABT<\/b> Abbott <span class=\"chg chg-down\">\u25bc3.09% $84.32<\/span><\/span><\/div>\n<img decoding=\"async\" alt=\"Roche\u65a5\u8cc7\u6700\u9ad810\u5104\u7f8e\u5143\u6536\u8cfcPathAI\uff0c\u5f37\u5316\u4eba\u5de5\u667a\u6167\u8a3a\u65b7\u80fd\u529b\" class=\"lazyload c-img\" height=\"540\" loading=\"lazy\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271170%27%20height%3D%27540%27%20viewBox%3D%270%200%201170%20540%27%3E%3Crect%20width%3D%271170%27%20height%3D%27540%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/witology.com.tw\/wp-content\/uploads\/2026\/05\/featured_2-11.png\" width=\"1170\"\/>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Roche\u5ba3\u5e03\u6536\u8cfcAI\u75c5\u7406\u8a3a\u65b7\u65b0\u5275PathAI\uff0c\u4ea4\u6613\u91d1\u984d\u6700\u9ad8\u905410\u5104\u7f8e\u5143\uff0c\u9019\u662f\u88fd\u85e5\u5de8\u982d\u5728AI\u8a3a\u65b7\u9818\u57df\u7684\u91cd\u5927\u5e03\u5c40\u3002PathAI\u5c08\u7cbe\u65bc\u5229\u7528\u6a5f\u5668\u5b78\u7fd2\u5206\u6790\u75c5\u7406\u5207\u7247\uff0c\u63d0\u5347\u764c\u75c7\u8a3a\u65b7\u7684\u6e96\u78ba\u6027\u8207\u6548\u7387\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403AI\u91ab\u5b78\u5f71\u50cf\u8a3a\u65b7\u5e02\u5834\u9810\u8a08\u5f9e2023\u5e74\u768415\u5104\u7f8e\u5143\u6210\u9577\u81f32030\u5e74\u7684148\u5104\u7f8e\u5143\u3002PathAI\u5df2\u8207\u8d85\u904e20\u5bb6\u88fd\u85e5\u516c\u53f8\u5408\u4f5c\uff0c\u5176AI\u6f14\u7b97\u6cd5\u53ef\u5c07\u75c5\u7406\u8a3a\u65b7\u6e96\u78ba\u7387\u63d0\u5347\u81f395%\u4ee5\u4e0a\uff0c\u8f03\u50b3\u7d71\u4eba\u5de5\u5224\u8b80\u63d0\u534710-15%\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>\u9019\u9805\u4f75\u8cfc\u4ee3\u8868\u50b3\u7d71\u88fd\u85e5\u5de8\u982d\u6b63\u7a4d\u6975\u6574\u5408AI\u8a3a\u65b7\u80fd\u529b\uff0c\u5c07\u6539\u8b8a\u5f9e\u85e5\u7269\u958b\u767c\u5230\u60a3\u8005\u6cbb\u7642\u7684\u6574\u500b\u50f9\u503c\u93c8\u3002Roche\u900f\u904e\u4f75\u8cfcPathAI\u4e0d\u50c5\u5f37\u5316\u5176\u8a3a\u65b7\u90e8\u9580\u7af6\u722d\u529b\uff0c\u66f4\u53ef\u5c07AI\u75c5\u7406\u5206\u6790\u6574\u5408\u81f3\u4f34\u96a8\u5f0f\u8a3a\u65b7\uff0c\u63d0\u5347\u500b\u4eba\u5316\u91ab\u7642\u7684\u7cbe\u6e96\u5ea6\u3002\u6b64\u8209\u5c07\u4fc3\u4f7f\u5176\u4ed6\u5927\u5ee0\u52a0\u901f\u5e03\u5c40AI\u8a3a\u65b7\u9818\u57df\uff0c\u63a8\u52d5\u6574\u500b\u7cbe\u6e96\u91ab\u7642\u7522\u696d\u7684\u767c\u5c55\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>AI\u75c5\u7406\u8a3a\u65b7\u96d6\u5177\u6280\u8853\u512a\u52e2\uff0c\u4f46\u76e3\u7ba1\u8a8d\u8b49\u6642\u7a0b\u5197\u9577\uff0c\u4e14\u91ab\u5e2b\u63a5\u53d7\u5ea6\u4ecd\u5f85\u63d0\u5347\uff0c10\u5104\u7f8e\u5143\u4f30\u503c\u662f\u5426\u53cd\u6620\u771f\u5be6\u5546\u696d\u50f9\u503c\u5b58\u7591\uff0c\u77ed\u671f\u5167\u96e3\u4ee5\u7522\u751f\u5c0d\u7b49\u7684\u71df\u6536\u8ca2\u737b\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>PathAI\u6574\u5408\u81f3Roche\u8a3a\u65b7\u90e8\u9580\u7684\u6642\u7a0b<\/li><li>\u5176\u4ed6\u5927\u5ee0\u8ddf\u9032AI\u8a3a\u65b7\u4f75\u8cfc\u7684\u52d5\u4f5c<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>AI\u75c5\u7406\u8a3a\u65b7\u7522\u54c1\u7684FDA\u8a8d\u8b49\u9032\u5c55<\/li><li>Roche\u8a3a\u65b7\u90e8\u9580\u71df\u6536\u6210\u9577\u8868\u73fe<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>AI\u8a3a\u65b7\u6a19\u6e96\u5316\u8207\u4e92\u64cd\u4f5c\u6027\u5efa\u7acb<\/li><li>\u50b3\u7d71\u75c5\u7406\u79d1\u91ab\u5e2b\u89d2\u8272\u8f49\u63db<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>10\u5104\u7f8e\u5143\u6536\u8cfcPathAI\u503c\u5f97\u55ce\uff1f<\/summary><p>\u4ee5AI\u91ab\u7642\u5f71\u50cf\u5e02\u5834\u7684\u9ad8\u6210\u9577\u6f5b\u529b\u4f86\u770b\u5408\u7406\uff0c\u4f46\u95dc\u9375\u5728PathAI\u6280\u8853\u80fd\u5426\u9806\u5229\u901a\u904e\u76e3\u7ba1\u8a8d\u8b49\u4e26\u5feb\u901f\u5546\u696d\u5316\uff0c\u9810\u671f2-3\u5e74\u5167\u53ef\u898b\u521d\u6b65\u6210\u6548\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>AI\u75c5\u7406\u8a3a\u65b7\u6703\u53d6\u4ee3\u91ab\u5e2b\u55ce\uff1f<\/summary><p>AI\u4e3b\u8981\u626e\u6f14\u8f14\u52a9\u89d2\u8272\uff0c\u63d0\u5347\u8a3a\u65b7\u6548\u7387\u8207\u4e00\u81f4\u6027\uff0c\u4f46\u6700\u7d42\u8a3a\u65b7\u6c7a\u7b56\u4ecd\u9700\u91ab\u5e2b\u5224\u65b7\uff0c\u9810\u671f\u5c07\u6539\u8b8a\u91ab\u5e2b\u5de5\u4f5c\u6a21\u5f0f\u800c\u975e\u5b8c\u5168\u53d6\u4ee3\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u53f0\u7063\u8a3a\u65b7\u696d\u8005\u6709\u7af6\u722d\u512a\u52e2\u55ce\uff1f<\/summary><p>\u53f0\u7063\u696d\u8005\u5982\u4e9e\u8afe\u6cd5\u5728\u5206\u5b50\u8a3a\u65b7\u3001\u666e\u751f\u5728\u5feb\u7be9\u9818\u57df\u6709\u57fa\u790e\uff0c\u53ef\u7d50\u5408AI\u6280\u8853\u767c\u5c55\u5dee\u7570\u5316\u7522\u54c1\uff0c\u4f46\u5728\u5f71\u50cfAI\u65b9\u9762\u4ecd\u9700\u52a0\u5f37\u6280\u8853\u6295\u8cc7\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/medtech\/roche-shell-out-1b-acquire-pathai-move-boost-ai-based-dx-algorithms\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-dn\">\u25bc \u504f\u7a7a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/ascendis-axes-il-2-program-retreat-oncology-expansion\" rel=\"noopener nofollow\" target=\"_blank\">Ascendis\u7d42\u6b62IL-2\u8a08\u756b\uff0c\u5f9e\u816b\u7624\u5b78\u64f4\u5f35\u4e2d\u64a4\u9000<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-05-11\" itemprop=\"datePublished\">2026-05-11<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cb\u25cb\u25cb<\/span><span class=\"c-hype-tx\">2\/5 \u00b7 \u6b21\u8981\u52d5\u614b<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>ASND<\/b> Ascendis Pharma <span class=\"chg chg-down\">\u25bc3.04% $238.66<\/span><\/span><span class=\"stk stk-other\">Synthorx <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><span class=\"stk stk-other\"><b>3176<\/b> \u57fa\u4e9e <span class=\"chg chg-down\">\u25bc0.91% $32.75<\/span><\/span><span class=\"stk stk-other\"><b>4743<\/b> \u5408\u4e00 <span class=\"chg chg-down\">\u25bc0.78% $51.2<\/span><\/span><span class=\"stk stk-us\"><b>REGN<\/b> Regeneron <span class=\"chg chg-up\">\u25b20.82% $714.89<\/span><\/span><span class=\"stk stk-us\"><b>GILD<\/b> Gilead <span class=\"chg chg-down\">\u25bc2.04% $131.33<\/span><\/span><span class=\"stk stk-us\"><b>BMY<\/b> Bristol Myers Squibb <span class=\"chg chg-down\">\u25bc0.16% $56.16<\/span><\/span><\/div>\n<img decoding=\"async\" alt=\"Ascendis\u7d42\u6b62IL-2\u8a08\u756b\uff0c\u5f9e\u816b\u7624\u5b78\u64f4\u5f35\u4e2d\u64a4\u9000\" class=\"lazyload c-img\" height=\"540\" loading=\"lazy\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271170%27%20height%3D%27540%27%20viewBox%3D%270%200%201170%20540%27%3E%3Crect%20width%3D%271170%27%20height%3D%27540%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/witology.com.tw\/wp-content\/uploads\/2026\/05\/featured_3-12.png\" width=\"1170\"\/>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u4e39\u9ea5\u751f\u6280\u516c\u53f8Ascendis Pharma\u5ba3\u5e03\u7d42\u6b62\u5176IL-2\u816b\u7624\u514d\u75ab\u6cbb\u7642\u8a08\u756b\uff0c\u4e26\u5c07\u8cc7\u6e90\u91cd\u65b0\u805a\u7126\u65bc\u5167\u5206\u6ccc\u75be\u75c5\u9818\u57df\u3002\u9019\u9805\u6c7a\u5b9a\u53cd\u6620\u4e86\u816b\u7624\u514d\u75ab\u6cbb\u7642\u7af6\u722d\u6fc0\u70c8\uff0c\u4ee5\u53caIL-2\u7642\u6cd5\u958b\u767c\u7684\u6280\u8853\u6311\u6230\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>Ascendis\u57282019\u5e74\u4ee5\u7d041.5\u5104\u7f8e\u5143\u6536\u8cfcSynthorx\u53d6\u5f97IL-2\u6280\u8853\u5e73\u53f0\u3002\u5168\u7403IL-2\u6cbb\u7642\u5e02\u5834\u9810\u8a082030\u5e74\u53ef\u905425\u5104\u7f8e\u5143\uff0c\u4f46\u76ee\u524d\u50c5\u6709\u5c11\u6578\u7522\u54c1\u7372\u5f97FDA\u6838\u51c6\uff0c\u6210\u529f\u7387\u7d04\u70ba15%\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Ascendis\u9000\u51fa\u816b\u7624\u5b78\u9818\u57df\u986f\u793a\u5373\u4f7f\u662f\u5275\u65b0\u7684IL-2\u6539\u826f\u6280\u8853\uff0c\u5728\u9762\u5c0d\u6fc0\u70c8\u7af6\u722d\u8207\u9ad8\u958b\u767c\u98a8\u96aa\u6642\u4ecd\u96e3\u4ee5\u70ba\u7e7c\u3002\u9019\u53cd\u6620\u4e86\u751f\u6280\u516c\u53f8\u5728\u8cc7\u6e90\u6709\u9650\u60c5\u6cc1\u4e0b\uff0c\u5fc5\u9808\u505a\u51fa\u7b56\u7565\u6027\u9078\u64c7\uff0c\u5c08\u6ce8\u65bc\u6700\u5177\u7af6\u722d\u512a\u52e2\u7684\u6cbb\u7642\u9818\u57df\u3002\u6b64\u8209\u4e5f\u63d0\u9192\u6295\u8cc7\u8005\uff0c\u816b\u7624\u514d\u75ab\u6cbb\u7642\u96d6\u7136\u524d\u666f\u770b\u597d\uff0c\u4f46\u6280\u8853\u9580\u6abb\u9ad8\u3001\u7af6\u722d\u6fc0\u70c8\uff0c\u4e2d\u5c0f\u578b\u751f\u6280\u516c\u53f8\u9762\u81e8\u66f4\u5927\u6311\u6230\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>Ascendis\u5c08\u6ce8\u5167\u5206\u6ccc\u75be\u75c5\u53ef\u80fd\u662f\u660e\u667a\u9078\u64c7\uff0c\u8a72\u9818\u57df\u7af6\u722d\u76f8\u5c0d\u8f03\u5c11\u4e14\u516c\u53f8\u5df2\u6709\u6210\u529f\u7522\u54c1\u57fa\u790e\uff0c\u653e\u68c4IL-2\u8a08\u756b\u96d6\u77ed\u671f\u8ca0\u9762\uff0c\u4f46\u9577\u671f\u53ef\u63d0\u5347\u8cc7\u6e90\u914d\u7f6e\u6548\u7387\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Ascendis Q4\u8ca1\u5831\u4e2d\u8cc7\u7522\u6e1b\u640d\u8a8d\u5217<\/li><li>\u7ba1\u7406\u5c64\u5c0d\u672a\u4f86\u7b56\u7565\u91cd\u9ede\u8aaa\u660e<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u5167\u5206\u6ccc\u75be\u75c5\u7522\u54c1\u7dda\u7814\u767c\u9032\u5c55<\/li><li>\u5176\u4ed6IL-2\u958b\u767c\u696d\u8005\u7684\u7af6\u722d\u52d5\u614b<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u4e2d\u5c0f\u578b\u751f\u6280\u516c\u53f8\u6cbb\u7642\u9818\u57df\u805a\u7126\u8da8\u52e2<\/li><li>IL-2\u6cbb\u7642\u6280\u8853\u7a81\u7834\u8207\u5e02\u5834\u91cd\u65b0\u6d17\u724c<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u70ba\u4ec0\u9ebcAscendis\u8981\u653e\u68c4IL-2\u816b\u7624\u6cbb\u7642\uff1f<\/summary><p>\u4e3b\u8981\u56e0\u70ba\u816b\u7624\u514d\u75ab\u6cbb\u7642\u7af6\u722d\u6fc0\u70c8\uff0cIL-2\u6539\u826f\u6280\u8853\u958b\u767c\u6210\u672c\u9ad8\u4e14\u98a8\u96aa\u5927\uff0c\u516c\u53f8\u6c7a\u5b9a\u5c07\u6709\u9650\u8cc7\u6e90\u96c6\u4e2d\u65bc\u66f4\u6709\u7af6\u722d\u512a\u52e2\u7684\u5167\u5206\u6ccc\u75be\u75c5\u9818\u57df\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>IL-2\u6cbb\u7642\u9084\u6709\u524d\u666f\u55ce\uff1f<\/summary><p>IL-2\u514d\u75ab\u6cbb\u7642\u4ecd\u6709\u6f5b\u529b\uff0c\u4f46\u9700\u8981\u66f4\u5275\u65b0\u7684\u6280\u8853\u5e73\u53f0\u4f86\u89e3\u6c7a\u6bd2\u6027\u8207\u7642\u6548\u554f\u984c\uff0c\u76ee\u524d\u4ecd\u6709\u591a\u5bb6\u5927\u5ee0\u5982Regeneron\u3001Gilead\u5728\u6301\u7e8c\u6295\u8cc7\u76f8\u95dc\u7814\u767c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u5c0d\u53f0\u7063\u816b\u7624\u65b0\u85e5\u958b\u767c\u6709\u4ec0\u9ebc\u555f\u793a\uff1f<\/summary><p>\u53f0\u7063\u751f\u6280\u516c\u53f8\u5982\u57fa\u4e9e\u3001\u5408\u4e00\u7b49\u5728\u816b\u7624\u85e5\u7269\u958b\u767c\u4e0a\u61c9\u66f4\u8b39\u614e\u8a55\u4f30\u7af6\u722d\u74b0\u5883\u8207\u6280\u8853\u5dee\u7570\u5316\uff0c\u907f\u514d\u5728\u7d05\u6d77\u5e02\u5834\u4e2d\u6d88\u8017\u904e\u591a\u8cc7\u6e90\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/ascendis-axes-il-2-program-retreat-oncology-expansion\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/blackstone-invests-250m-anagram-reduce-burden-cf-complication\" rel=\"noopener nofollow\" target=\"_blank\">Blackstone invests $250M in Anagram to reduce burden of cystic fibrosis complication<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#70AD47\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/pharma\/fda-reconsider-surprisingly-rejected-cell-therapy-ebvallo-could-uniqure-be-next\" rel=\"noopener nofollow\" target=\"_blank\">FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?<\/a>\n<span class=\"b-meta\">\u65b0\u8208\u7642\u6cd5 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#70AD47\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/research\/protective-gene-sent-liver-cleared-amyloid-mouse-brains-sparking-hope-alzheimers-gene\" rel=\"noopener nofollow\" target=\"_blank\">A protective gene sent to the liver cleared amyloid from mouse brains, sparking hope for an Alzheimer&#8217;s gene therapy<\/a>\n<span class=\"b-meta\">\u65b0\u8208\u7642\u6cd5 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#ED7D31\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/medtech\/new-hepta-blood-test-could-predict-glp-1-response\" rel=\"noopener nofollow\" target=\"_blank\">New Hepta blood test could predict GLP-1 response<\/a>\n<span class=\"b-meta\">\u91ab\u7642\u5668\u6750 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#FFC000\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/news.google.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?oc=5\" rel=\"noopener nofollow\" target=\"_blank\">ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&amp;D &#8211; The Manila Times<\/a>\n<span class=\"b-meta\">\u751f\u547d\u79d1\u5b78 \u00b7 Google News &#8211; biopharmaceutical<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#70AD47\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/news.google.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?oc=5\" rel=\"noopener nofollow\" target=\"_blank\">Is Sana Biotechnology&#8217;s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story? &#8211; simplywall.st<\/a>\n<span class=\"b-meta\">\u65b0\u8208\u7642\u6cd5 \u00b7 Google News &#8211; biotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/odyssey-voyages-nasdaq-304m-ipo-fund-autoimmune-inflammatory-pipeline\" rel=\"noopener nofollow\" target=\"_blank\">Odyssey&#8217;s CEO sees $304M IPO as chance to create a &#8216;little large pharma&#8217;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:38.46153846153847%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">5<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:23.076923076923077%;background:#ED7D31\"><\/div><span class=\"st-lb\">\u91ab\u7642\u5668\u6750<\/span><span class=\"st-ct\">3<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:23.076923076923077%;background:#70AD47\"><\/div><span class=\"st-lb\">\u65b0\u8208\u7642\u6cd5<\/span><span class=\"st-ct\">3<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:7.6923076923076925%;background:#FFC000\"><\/div><span class=\"st-lb\">\u751f\u547d\u79d1\u5b78<\/span><span class=\"st-ct\">1<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:7.6923076923076925%;background:#5B9BD5\"><\/div><span class=\"st-lb\">\u6578\u4f4d\u5065\u5eb7\u91ab\u7642\u79d1\u6280<\/span><span class=\"st-ct\">1<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 05 \u6708 11 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 13 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 3 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-05-11\uff5c\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d","rank_math_description":"2026 \u5e74 05 \u6708 11 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1a\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d\u3001Roche\u65a5\u8cc7\u6700\u9ad810\u5104\u7f8e\u5143\u6536\u8cfcPathAI\uff0c\u5f37\u5316\u4eba\u5de5\u667a\u6167\u8a3a\u65b7\u80fd\u529b\u3002\u5171\u6536\u9304 13 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-05-11\uff5c\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d\",\n    \"description\": \"2026 \u5e74 05 \u6708 11 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1a\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d\u3001Roche\u65a5\u8cc7\u6700\u9ad810\u5104\u7f8e\u5143\u6536\u8cfcPathAI\uff0c\u5f37\u5316\u4eba\u5de5\u667a\u6167\u8a3a\u65b7\u80fd\u529b\u3002\u5171\u6536\u9304 13 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-05-11\",\n    \"datePublished\": \"2026-05-11\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"\u5f9e\u85e5\u7269\u958b\u767c\u5230\u4f75\u8cfc\uff0c\u5927\u578b\u85e5\u5ee0\u5c55\u73feAI\u7684\u300c\u53ef\u8861\u91cf\u5f71\u97ff\u529b\u300d\",\n        \"datePublished\": \"2026-05-11\",\n        \"dateModified\": \"2026-05-11\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/daily\/2026-05-11\/featured_1.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-05-11#article-1\"\n        },\n        \"description\": \"\u5168\u7403\u4e3b\u8981\u88fd\u85e5\u5ee0\u5546\u958b\u59cb\u516c\u958b\u5c55\u793a\u4eba\u5de5\u667a\u6167\u5728\u85e5\u7269\u7814\u767c\u5404\u968e\u6bb5\u7684\u5be6\u969b\u61c9\u7528\u6210\u6548\uff0c\u5f9e\u65e9\u671f\u5316\u5408\u7269\u7be9\u9078\u5230\u4f75\u8cfc\u6a19\u7684\u8a55\u4f30\u90fd\u6709\u91cf\u5316\u6578\u64da\u652f\u6490\u3002\u9019\u6a19\u8a8c\u8457\u88fd\u85e5\u7522\u696dAI\u61c9\u7528\u5f9e\u6982\u5ff5\u9a57\u8b49\u968e\u6bb5\u9032\u5165\u898f\u6a21\u5316\u5546\u696d\u90e8\u7f72\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-05-11#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/drug-development-ma-big-pharmas-showcase-measurable-impact-ai\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Pfizer\",\n            \"tickerSymbol\": \"PFE\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novartis\",\n            \"tickerSymbol\": \"NVS\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"ROG\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Johnson & Johnson\",\n            \"tickerSymbol\": \"JNJ\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AstraZeneca\",\n            \"tickerSymbol\": \"AZN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e9e\u8afe\u6cd5\",\n            \"tickerSymbol\": \"4133\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u57fa\u4e9e\",\n            \"tickerSymbol\": \"3176\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Roche\u65a5\u8cc7\u6700\u9ad810\u5104\u7f8e\u5143\u6536\u8cfcPathAI\uff0c\u5f37\u5316\u4eba\u5de5\u667a\u6167\u8a3a\u65b7\u80fd\u529b\",\n        \"datePublished\": \"2026-05-11\",\n        \"dateModified\": \"2026-05-11\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/daily\/2026-05-11\/featured_2.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-05-11#article-2\"\n        },\n        \"description\": \"Roche\u5ba3\u5e03\u6536\u8cfcAI\u75c5\u7406\u8a3a\u65b7\u65b0\u5275PathAI\uff0c\u4ea4\u6613\u91d1\u984d\u6700\u9ad8\u905410\u5104\u7f8e\u5143\uff0c\u9019\u662f\u88fd\u85e5\u5de8\u982d\u5728AI\u8a3a\u65b7\u9818\u57df\u7684\u91cd\u5927\u5e03\u5c40\u3002PathAI\u5c08\u7cbe\u65bc\u5229\u7528\u6a5f\u5668\u5b78\u7fd2\u5206\u6790\u75c5\u7406\u5207\u7247\uff0c\u63d0\u5347\u764c\u75c7\u8a3a\u65b7\u7684\u6e96\u78ba\u6027\u8207\u6548\u7387\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-05-11#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/medtech\/roche-shell-out-1b-acquire-pathai-move-boost-ai-based-dx-algorithms\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"ROG\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"PathAI\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e9e\u8afe\u6cd5\",\n            \"tickerSymbol\": \"4133\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u666e\u751f\",\n            \"tickerSymbol\": \"4117\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Illumina\",\n            \"tickerSymbol\": \"ILMN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Thermo Fisher\",\n            \"tickerSymbol\": \"TMO\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Abbott\",\n            \"tickerSymbol\": \"ABT\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Ascendis\u7d42\u6b62IL-2\u8a08\u756b\uff0c\u5f9e\u816b\u7624\u5b78\u64f4\u5f35\u4e2d\u64a4\u9000\",\n        \"datePublished\": \"2026-05-11\",\n        \"dateModified\": \"2026-05-11\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/daily\/2026-05-11\/featured_3.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-05-11#article-3\"\n        },\n        \"description\": \"\u4e39\u9ea5\u751f\u6280\u516c\u53f8Ascendis Pharma\u5ba3\u5e03\u7d42\u6b62\u5176IL-2\u816b\u7624\u514d\u75ab\u6cbb\u7642\u8a08\u756b\uff0c\u4e26\u5c07\u8cc7\u6e90\u91cd\u65b0\u805a\u7126\u65bc\u5167\u5206\u6ccc\u75be\u75c5\u9818\u57df\u3002\u9019\u9805\u6c7a\u5b9a\u53cd\u6620\u4e86\u816b\u7624\u514d\u75ab\u6cbb\u7642\u7af6\u722d\u6fc0\u70c8\uff0c\u4ee5\u53caIL-2\u7642\u6cd5\u958b\u767c\u7684\u6280\u8853\u6311\u6230\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-05-11#article-3\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/ascendis-axes-il-2-program-retreat-oncology-expansion\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Ascendis Pharma\",\n            \"tickerSymbol\": \"ASND\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Synthorx\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u57fa\u4e9e\",\n            \"tickerSymbol\": \"3176\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u5408\u4e00\",\n            \"tickerSymbol\": \"4743\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Regeneron\",\n            \"tickerSymbol\": \"REGN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Gilead\",\n            \"tickerSymbol\": \"GILD\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Bristol Myers Squibb\",\n            \"tickerSymbol\": \"BMY\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-05-11\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-05-11\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"AI\u771f\u7684\u80fd\u8b93\u65b0\u85e5\u958b\u767c\u8b8a\u5feb\u8b8a\u4fbf\u5b9c\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u76ee\u524dAI\u4e3b\u8981\u5728\u65e9\u671f\u85e5\u7269\u8a2d\u8a08\u968e\u6bb5\u5c55\u73fe\u512a\u52e2\uff0c\u80fd\u5c07\u5316\u5408\u7269\u7be9\u9078\u6642\u9593\u5f9e\u6578\u6708\u7e2e\u77ed\u81f3\u6578\u9031\uff0c\u4f46\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u7684\u52a0\u901f\u6548\u679c\u4ecd\u9700\u66f4\u591a\u5be6\u8b49\u6578\u64da\u652f\u6490\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u54ea\u4e9b\u88fd\u85e5\u516c\u53f8\u5728AI\u61c9\u7528\u4e0a\u8d70\u5f97\u6700\u524d\u9762\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"Roche\u3001Novartis\u3001Pfizer\u7b49\u5927\u5ee0\u900f\u904e\u5167\u90e8\u7814\u767c\u8207\u5916\u90e8\u4f75\u8cfc\u96d9\u8ecc\u4e26\u9032\uff0c\u800c\u65b0\u5275\u5982Recursion\u3001Exscientia\u7b49AI\u539f\u751f\u516c\u53f8\u5247\u5c08\u6ce8\u65bc\u5e73\u53f0\u6280\u8853\u958b\u767c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u53f0\u7063\u751f\u91ab\u516c\u53f8\u6709\u6a5f\u6703\u5728AI\u85e5\u7269\u958b\u767c\u6f6e\u6d41\u4e2d\u53d7\u76ca\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063\u7684CDMO\u696d\u8005\u5982\u4fdd\u745e\u3001\u53f0\u5eb7\u53ef\u627f\u63a5AI\u8a2d\u8a08\u85e5\u7269\u7684\u4ee3\u5de5\u9700\u6c42\uff0c\u800c\u4e9e\u8afe\u6cd5\u7b49\u9ad4\u5916\u8a3a\u65b7\u516c\u53f8\u5247\u53ef\u7d50\u5408AI\u6280\u8853\u63d0\u5347\u7cbe\u6e96\u91ab\u7642\u80fd\u529b\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"10\u5104\u7f8e\u5143\u6536\u8cfcPathAI\u503c\u5f97\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u4ee5AI\u91ab\u7642\u5f71\u50cf\u5e02\u5834\u7684\u9ad8\u6210\u9577\u6f5b\u529b\u4f86\u770b\u5408\u7406\uff0c\u4f46\u95dc\u9375\u5728PathAI\u6280\u8853\u80fd\u5426\u9806\u5229\u901a\u904e\u76e3\u7ba1\u8a8d\u8b49\u4e26\u5feb\u901f\u5546\u696d\u5316\uff0c\u9810\u671f2-3\u5e74\u5167\u53ef\u898b\u521d\u6b65\u6210\u6548\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"AI\u75c5\u7406\u8a3a\u65b7\u6703\u53d6\u4ee3\u91ab\u5e2b\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"AI\u4e3b\u8981\u626e\u6f14\u8f14\u52a9\u89d2\u8272\uff0c\u63d0\u5347\u8a3a\u65b7\u6548\u7387\u8207\u4e00\u81f4\u6027\uff0c\u4f46\u6700\u7d42\u8a3a\u65b7\u6c7a\u7b56\u4ecd\u9700\u91ab\u5e2b\u5224\u65b7\uff0c\u9810\u671f\u5c07\u6539\u8b8a\u91ab\u5e2b\u5de5\u4f5c\u6a21\u5f0f\u800c\u975e\u5b8c\u5168\u53d6\u4ee3\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u53f0\u7063\u8a3a\u65b7\u696d\u8005\u6709\u7af6\u722d\u512a\u52e2\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063\u696d\u8005\u5982\u4e9e\u8afe\u6cd5\u5728\u5206\u5b50\u8a3a\u65b7\u3001\u666e\u751f\u5728\u5feb\u7be9\u9818\u57df\u6709\u57fa\u790e\uff0c\u53ef\u7d50\u5408AI\u6280\u8853\u767c\u5c55\u5dee\u7570\u5316\u7522\u54c1\uff0c\u4f46\u5728\u5f71\u50cfAI\u65b9\u9762\u4ecd\u9700\u52a0\u5f37\u6280\u8853\u6295\u8cc7\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u70ba\u4ec0\u9ebcAscendis\u8981\u653e\u68c4IL-2\u816b\u7624\u6cbb\u7642\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u4e3b\u8981\u56e0\u70ba\u816b\u7624\u514d\u75ab\u6cbb\u7642\u7af6\u722d\u6fc0\u70c8\uff0cIL-2\u6539\u826f\u6280\u8853\u958b\u767c\u6210\u672c\u9ad8\u4e14\u98a8\u96aa\u5927\uff0c\u516c\u53f8\u6c7a\u5b9a\u5c07\u6709\u9650\u8cc7\u6e90\u96c6\u4e2d\u65bc\u66f4\u6709\u7af6\u722d\u512a\u52e2\u7684\u5167\u5206\u6ccc\u75be\u75c5\u9818\u57df\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"IL-2\u6cbb\u7642\u9084\u6709\u524d\u666f\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"IL-2\u514d\u75ab\u6cbb\u7642\u4ecd\u6709\u6f5b\u529b\uff0c\u4f46\u9700\u8981\u66f4\u5275\u65b0\u7684\u6280\u8853\u5e73\u53f0\u4f86\u89e3\u6c7a\u6bd2\u6027\u8207\u7642\u6548\u554f\u984c\uff0c\u76ee\u524d\u4ecd\u6709\u591a\u5bb6\u5927\u5ee0\u5982Regeneron\u3001Gilead\u5728\u6301\u7e8c\u6295\u8cc7\u76f8\u95dc\u7814\u767c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u5c0d\u53f0\u7063\u816b\u7624\u65b0\u85e5\u958b\u767c\u6709\u4ec0\u9ebc\u555f\u793a\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063\u751f\u6280\u516c\u53f8\u5982\u57fa\u4e9e\u3001\u5408\u4e00\u7b49\u5728\u816b\u7624\u85e5\u7269\u958b\u767c\u4e0a\u61c9\u66f4\u8b39\u614e\u8a55\u4f30\u7af6\u722d\u74b0\u5883\u8207\u6280\u8853\u5dee\u7570\u5316\uff0c\u907f\u514d\u5728\u7d05\u6d77\u5e02\u5834\u4e2d\u6d88\u8017\u904e\u591a\u8cc7\u6e90\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-7567","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=7567"}],"version-history":[{"count":0,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7567\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=7567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}